zepbound semaglutide or tirzepatide Versus Wegovy: Head-to-Head Trial Reveals Which Has the Weight Loss Edge Semaglutide vs Tirzepatide: Head-to-Head for

We now know that GLP-1 medications can have an impact on the skin and hair

Common side effects include mild to moderate GI symptoms, but more serious health risks or complications may also occur in certain groups of people

Common GLP-1 medications and their approved uses include: Ozempic (semaglutide): for type 2 diabetes, used off-label for weight loss Wegovy (semaglutide): approved for chronic weight management Mounjaro (tirzepatide): for type 2 diabetes, with growing use for weight loss

For example, someone who begins a GLP-1 medication in January may notice increased shedding in March or April

Why the dose schedule cannot be rushed Clinical trial data from the phase 2 NEJM study revealed something critical about dose scheduling